| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.2M | — | -1.7% |
| SG&A Expense | $5.7M | — | +286.9% |
| Operating Income | -$7.9M | — | -113.8% |
| Interest Expense | $348K | — | +66.1% |
| Pre-tax Income | -$9.3M | — | -144.9% |
| Net Income | -$9.3M | — | -144.9% |
| EPS (Basic) | -$0.95 | — | +8.7% |
| EPS (Diluted) | -$0.95 | — | +8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.9M | +136.4% | +172.0% |
| Current Assets | $27.9M | +132.5% | +165.7% |
| Total Assets | $30.9M | +104.7% | +147.5% |
| Current Liabilities | $11.0M | +6.3% | +95.2% |
| Total Liabilities | $12.0M | -4.5% | +83.5% |
| Stockholders' Equity | $18.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.9M | — | -50.0% |
| Capital Expenditures | $61K | — | — |
| Investing Cash Flow | -$61K | — | — |
| Financing Cash Flow | $21.9M | — | +1043.8% |
| Free Cash Flow | -$7.0M | — | — |
| +218.1% |